Canopus BioPharma Incorporated CBIA Stock
Canopus BioPharma Incorporated Price Chart
Canopus BioPharma Incorporated CBIA Financial and Trading Overview
| Canopus BioPharma Incorporated stock price | 0.0002 USD |
| Previous Close | 0.06 USD |
| Open | 0.03 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.03 - 0.03 USD |
| 52 Week Range | 0.02 - 0.22 USD |
| Volume | 61.17K USD |
| Avg. Volume | 11.53K USD |
| Market Cap | 269.7K USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CBIA Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Canopus BioPharma Incorporated Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -39.99% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.22 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.08 USD |
| 200-Day Moving Average | 0.06 USD |
CBIA Share Statistics
| Avg. Volume (3 month) | 11.53K USD |
| Avg. Daily Volume (10-Days) | 51.11K USD |
| Shares Outstanding | 9.3M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Canopus BioPharma Incorporated
| Country | United States |
| State | CA |
| City | Santa Monica |
| Address | 233 Wilshire Boulevard |
| ZIP | 90401 |
| Phone | 353-627-8674 |
| Website | N/A |
| Industry | Advertising Agencies |
| Sector(s) | Communication Services |
| Full Time Employees | N/A |
Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.
Q&A For Canopus BioPharma Incorporated Stock
What is a current CBIA stock price?
Canopus BioPharma Incorporated CBIA stock price today per share is 0.0002 USD.
How to purchase Canopus BioPharma Incorporated stock?
You can buy CBIA shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Canopus BioPharma Incorporated?
The stock symbol or ticker of Canopus BioPharma Incorporated is CBIA.
Which industry does the Canopus BioPharma Incorporated company belong to?
The Canopus BioPharma Incorporated industry is Advertising Agencies.
How many shares does Canopus BioPharma Incorporated have in circulation?
The max supply of Canopus BioPharma Incorporated shares is 2.79B.
What is Canopus BioPharma Incorporated Price to Earnings Ratio (PE Ratio)?
Canopus BioPharma Incorporated PE Ratio is now.
What was Canopus BioPharma Incorporated earnings per share over the trailing 12 months (TTM)?
Canopus BioPharma Incorporated EPS is 0 USD over the trailing 12 months.
Which sector does the Canopus BioPharma Incorporated company belong to?
The Canopus BioPharma Incorporated sector is Communication Services.